Logo Image
|Articles|July 7, 2022

Pharmaceutical Executive

  • Pharmaceutical Executive-07-01-2022
  • Volume 42
  • Issue 7

Pharmaceutical Executive, July 2022 Issue (PDF)

Click cover to access PDF

Articles in this issue

almost 4 years ago

The True Nature of Danger Behind IP Waiver Proposal

almost 4 years ago

In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent Contractors

almost 4 years ago

Cracking Down on Speaker Programs

almost 4 years ago

Dynamic Compliance: The Best Defense for Pharma

almost 4 years ago

A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs

almost 4 years ago

Breaking Down Barriers

almost 4 years ago

Biotech Performance Glance—and Promising Ripples for Recovery

almost 4 years ago

If Non-Formulary Hospital, Price May Not Be the Rx

almost 4 years ago

When It Comes To DE&I, Silence Is Deafening

almost 4 years ago

Asia’s Rise in The Global Pharma Industry